Richter Gedeon Vegyeszeti Gyar Reszvenytarsasag Eesti Filiaal

Active Registry code 10039753 Välismaa äriühingu filiaal Tallinn Registered 20 Jun 1996
Compare

Richter Gedeon Vegyeszeti Gyar Reszvenytarsasag Eesti Filiaal is a Välismaa äriühingu filiaal based in Tallinn, registry code 10039753, status: active. Main activity: Manufacture of medicines and other pharmaceutical preparations. There is no EMTA tax data for this company on the site.

Turnover
—
State taxes
40 017 €
↑ 0.3% vs Q2 2026
Labour taxes
42 424 €
↑ 0.3% vs Q2 2026
Employees
8
+2 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Labour taxes per employee 5 303 €
    industry median 4 573 € · companies in the industry: 12

Taxes and turnover

Q4 2023 – Q3 2026
Labour taxes per employee, € Q3 2026: 5 303 € · −24.8% vs Q2 2026 · industry median 4 573 € · above 74% of the industry
02 5005 0007 50010 00012 500Q4 2023 Company: 5 683 € Industry median: 3 627 €Q4·23Q1 2024 Company: 12 272 € Industry median: 3 668 €Q2 2024 Company: 6 543 € Industry median: 3 706 €Q2·24Q3 2024 Company: 5 866 € Industry median: 3 971 €Q4 2024 Company: 4 990 € Industry median: 3 921 €Q4·24Q1 2025 Company: 7 080 € Industry median: 4 259 €Q2 2025 Company: 6 104 € Industry median: 3 971 €Q2·25Q3 2025 Company: 6 755 € Industry median: 4 236 €Q4 2025 Company: 6 203 € Industry median: 4 504 €Q4·25Q1 2026 Company: 6 382 € Industry median: 4 205 €Q2 2026 Company: 7 050 € Industry median: 4 757 €Q2·26Q3 2026 Company: 5 303 € Industry median: 4 573 €Q3·2602 0004 0006 0008 000Q4 2024 Company: 4 990 € Industry median: 3 921 €Q1 2025 Company: 7 080 € Industry median: 4 259 €Q1·25Q2 2025 Company: 6 104 € Industry median: 3 971 €Q3 2025 Company: 6 755 € Industry median: 4 236 €Q3·25Q4 2025 Company: 6 203 € Industry median: 4 504 €Q1 2026 Company: 6 382 € Industry median: 4 205 €Q1·26Q2 2026 Company: 7 050 € Industry median: 4 757 €Q3 2026 Company: 5 303 € Industry median: 4 573 €Q3·26
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 8 · +33.3% vs Q2 2026
02468Q4 2023 Company: 6Q4·23Q1 2024 Company: 5Q2 2024 Company: 5Q2·24Q3 2024 Company: 6Q4 2024 Company: 6Q4·24Q1 2025 Company: 7Q2 2025 Company: 7Q2·25Q3 2025 Company: 7Q4 2025 Company: 7Q4·25Q1 2026 Company: 7Q2 2026 Company: 6Q2·26Q3 2026 Company: 8Q3·2602468Q4 2024 Company: 6Q1 2025 Company: 7Q1·25Q2 2025 Company: 7Q3 2025 Company: 7Q3·25Q4 2025 Company: 7Q1 2026 Company: 7Q1·26Q2 2026 Company: 6Q3 2026 Company: 8Q3·26
State taxes, € Q3 2026: 40 017 € · +0.3% vs Q2 2026
020 00040 00060 000Q4 2023 Company: 4 300 €Q4·23Q1 2024 Company: 59 438 €Q2 2024 Company: 31 103 €Q2·24Q3 2024 Company: 33 231 €Q4 2024 Company: 28 295 €Q4·24Q1 2025 Company: 19 020 €Q2 2025 Company: 40 574 €Q2·25Q3 2025 Company: 44 569 €Q4 2025 Company: 5 148 €Q4·25Q1 2026 Company: 42 264 €Q2 2026 Company: 39 914 €Q2·26Q3 2026 Company: 40 017 €Q3·26010 00020 00030 00040 00050 000Q4 2024 Company: 28 295 €Q1 2025 Company: 19 020 €Q1·25Q2 2025 Company: 40 574 €Q3 2025 Company: 44 569 €Q3·25Q4 2025 Company: 5 148 €Q1 2026 Company: 42 264 €Q1·26Q2 2026 Company: 39 914 €Q3 2026 Company: 40 017 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — 40 017 42 424 8
Q2 2026 — 39 914 42 298 6
Q1 2026 — 42 264 44 673 7
Q4 2025 — 5 148 43 424 7
Q3 2025 — 44 569 47 287 7
Q2 2025 — 40 574 42 731 7
Q1 2025 — 19 020 49 559 7
Q4 2024 — 28 295 29 940 6
Q3 2024 — 33 231 35 197 6
Q2 2024 — 31 103 32 713 5
Q1 2024 — 59 438 61 360 5
Q4 2023 — 4 300 34 096 6
Q3 2023 — 41 501 43 677 6
Q2 2023 — 31 706 33 016 6
Q1 2023 — 38 206 40 158 6
Q4 2022 — 411 33 060 6
Q3 2022 — 32 890 34 715 6
Q2 2022 — 33 290 35 080 6
Q1 2022 — 36 479 38 319 6
Labour taxes per employee per month
1 768 €

Q3 2026 · calculated from EMTA data

Board

Right of representation

Any branch manager may represent the branch in all transactions.

Owners

No owner information.

Activities (EMTAK)

  • 21201Manufacture of medicines and other pharmaceutical preparations Main
Rulings
Number, date Title Deadline State Document
Ä 20000768 / 9
12 Jul 2024
Amendment entry In force
12 Jul 2024
PDF
Ä 20000768 / 8
2 Feb 2024
Amendment entry In force
2 Feb 2024
PDF
Ä 20000768 / 7
28 Sep 2022
Amendment under Commercial Code § 525 (2) In force
28 Sep 2022
PDF
Ä 20000768 / 6
18 Jan 2018
Amendment entry In force
18 Jan 2018
PDF
Ä 20000768 / 5
3 Dec 2017
Amendment entry In force
3 Dec 2017
PDF
Ä 20000768 / 4
6 Jul 2017
Amendment entry In force
6 Jul 2017
PDF
Ä 20000768 / 3
17 May 2016
Amendment entry In force
17 May 2016
PDF
Ä 20000768 / 2
30 Mar 2016
Amendment entry In force
30 Mar 2016
PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data